EN | DE

Dr Virgyl Camberlein

About

Virgyl Camberlein graduated from the School of Pharmacy in Lille, France, in 2018 and obtained his M.Sc. in Medicinal Chemistry the same year, on the design and optimization of metalloprotease inhibitors. He received his Ph.D. from the University of Lille and the Saarland University, in 2022 within the groups of Prof. Dr. Deprez-Poulain (Lille, France) and Prof. Dr. Hirsch (Saarbrücken, Germany), focusing on protein-templated reactions and metalloprotease inhibitors. In February 2022, he started his first post-doctoral position in the group of Prof. Dr. Hirsch where he is involved in the design and optimization of metalloprotease inhibitors.